Achieving optimal glycemic control in Type 1 diabetes requires a sophisticated balance of insulin regimens, monitoring technologies, and lifestyle management. These flashcards are designed to help pharmacists and healthcare professionals quickly recall the Diabetes Canada Clinical Practice Guidelines recommendations for basal-bolus therapy, pump usage, and the integration of new technologies like continuous glucose monitoring.
Key Topics Covered:
Insulin Regimens: Differentiating between Multiple Daily Injections (MDI) and Continuous Subcutaneous Insulin Infusion (CSII) as standards of care.
Pharmacotherapy: Understanding the advantages of rapid-acting and long-acting insulin analogues over older formulations for reducing hypoglycemia and improving A1C.
Technology & Monitoring: Identifying the specific benefits of Real-Time Continuous Glucose Monitoring (rtCGM) and Sensor-Augmented Pumps (SAP) for high-risk individuals.
Hypoglycemia Prevention: Reviewing strategies for patients with hypoglycemia unawareness, including standardized education and technology.
Adjunctive Therapies: Recalling the current evidence and limitations regarding non-insulin agents like metformin, GLP-1 receptor agonists, and SGLT2 inhibitors.